French beauty giant eyes $35-45M deal for Gurugram-based Innovist (Bare Anatomy)—co-founder Rohit Chawla’s second FMCG exit after Man Company sale.
L’Oréal negotiating controlling stake in Innovist, the D2C startup behind Bare Anatomy skincare—deal valued ₹320-420 Cr.
L’Oréal India is in advanced bilateral talks to acquire majority controlling stake in Gurugram-based D2C personal care startup Innovist, valued at $35-45 million (₹320-420 crore). The proposed transaction marks second major exit for co-founder Rohit Chawla after Man Company sale to Emami.
Deal Structure Detailed
Staggered/phased execution planned: First leg L’Oréal acquires controlling stake; post-2 years gradual roadshow for remaining 100%. Quantum stake first leg/seller details unclear.
Founder Rohit Chawla holds 49.7% stake per latest Tracxn data. Peak XV, ICICI Ventures, Patni Financial among cap table VCs.
Innovist Financial Snapshot
Company profitable FY26; comparable consumer brands trade 4-6x revenue multiples.
Strategic Fit for L’Oréal
L’Oréal Global CEO Nicolas Hieronimus Feb call: “India fifth largest growth contributor after GCC. Revised strategy new team—we fantastic launches CeraVe La Roche-Posay”.
India 1% L’Oréal turnover; strong hair care (Garnier #1). Innovist adds D2C muscle clean formulations. For more info read here.
Rohit Chawla’s Exit Playbook
First: Built Man Company (₹400 Cr valuation), sold Emami 2024
Second: Innovist Bare Anatomy (shampoos, serums, cleansers, creams)—potential L’Oréal control.
Chawla structured deals attract FMCG majors.
D2C Acquisition Boom Table
L’Oréal India Ambition
Hieronimus: “India ambitious—we high single-digit growth. New strategy where strong growth opportunities. Launched CeraVe La Roche-Posay”.
India hair care dominance; skincare expansion via Innovist.
Innovist Product Portfolio
Science-first house: Clean formulations transparent ingredients. Shampoos, serums, cleansers, creams, lip balms, sunscreens, body washes.
FY25 revenue ₹300 Cr (3x FY24 ₹100 Cr); FY24 loss ₹12 Cr → FY25 profit ₹12 Cr.
Beauty Segment Consolidation
Estée Lauder March acquired Forest Essentials stake. L’Oréal Innovist fits premium D2C push.
Unilever, Marico, ITC, Honasa lead D2C buys accessing insights scale.
Valuation Benchmarks
Innovist ₹320-420 Cr = 4.3-5.3x FY26 revenue. Comparable 4-6x standard.
Cap Table Snapshot
Founder: Rohit Chawla (49.7%)
VCs: Peak XV, ICICI Ventures, Patni Financial
Quantum: First leg controlling
Co-Founder Background
Rohit Chawla + Vimal Bhola built Innovist post-Man Company success. Queries L’Oréal India/co-founders unanswered.
FMCG-D2C Synergies
Acquisitions “win-win”: Corporates gain consumer insights; startups solve distribution/scale.
CEO Hieronimus Quotes
“As India concerned, I’m satisfied high single-digit growth… India 1% turnover small tech”.
Deal Timeline
Bilateral talks expected seal April if progress current pace. Stake sale works Innovist.
Market Context
Beauty/personal care India sees international players opt stakes (Estée Lauder Forest Essentials). L’Oréal revised India game plan.
Second Exit Significance
Chawla’s Innovist potentially second FMCG major exit after Man Company-Emami.
India D2C Valuation Trends
FY24 CAGR 30-40%; established FMCG 8%. Premium beauty ripe consolidation.
L’Oréal Growth
Drivers
GCC fifth largest; India ambitious cluster. Hair care #1 (Garnier); skincare expansion.
Innovist Growth Trajectory
FY25 ₹300 Cr revenue; FY26 ₹750 Cr target. Profitable turnaround FY25.
Verdict: Beauty D2C Power Play
L’Oréal’s $35-45M Innovist bid signals aggressive India premiumisation—Rohit Chawla’s second blockbuster exit. FMCG-D2C marriage accelerates as Hindustan Unilever, Marico lead charge.
L’Oréal’s bold Innovist acquisition reshapes India’s D2C beauty landscape forever.